ArticleFrontiers in pharmacology2024

Sotagliflozin versus dapagliflozin to improve outcome of patients with diabetes and worsening heart failure: a cost per outcome analysis.

Weichen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.